📄 "How Epstein Barr Virus Causes Lymphomas" . EBV ( November 27, 2024 at 11:38AM)
https://pubmed.ncbi.nlm.nih.gov/39599857/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241127093805&v=2.18.0.post9+e462414

📄 "Hodgkin lymphoma: the role of EBV plasma viral load testing in an HIV-endemic setting" . EBV ( November 26, 2024 at 02:58PM)
https://pubmed.ncbi.nlm.nih.gov/39589446/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241126125838&v=2.18.0.post9+e462414

📄 "Respondida: Recebi um manuscrito para avaliação; como efetuar uma revisão criteriosa e construtiva?" . ViriCan IEC ( November 29, 2024 at 08:55AM)
http://iec.elgui.net/?qa=141/manuscrito-avaliacao-efetuar-revisao-criteriosa-construtiva&show=142#a142

📄 "Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression" . Vírus e Câncer ( December 4, 2024 at 04:54AM)
https://pubmed.ncbi.nlm.nih.gov/39627192/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20241204025404&v=2.18.0.post9+e462414

📄 "Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein-Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma" . Vírus e Câncer ( December 4, 2024 at 04:54AM)
https://pubmed.ncbi.nlm.nih.gov/39626922/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20241204025404&v=2.18.0.post9+e462414

📄 "Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression" . EBV & Cancer progression ( December 5, 2024 at 12:32AM)
https://pubmed.ncbi.nlm.nih.gov/39627192/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=10YYOHVqhl36EY0bqDUZ-o6Zqp1ezlvhDjzC66JLR7q8SgUQQ6&fc=None&ff=20241204223236&v=2.18.0.post9+e462414

📄 "Features of hyperinflammation link the biology of EBV infection and cytokine storm syndromes" . EBV ( December 3, 2024 at 04:29AM)
https://pubmed.ncbi.nlm.nih.gov/39622297/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241203022910&v=2.18.0.post9+e462414

📄 "Viral Load Measurements for Kaposi Sarcoma Herpesvirus (KSHV/HHV8): Review and an Updated Assay" . KSHV/HHV-8 strains ( December 9, 2024 at 12:23PM)
https://pubmed.ncbi.nlm.nih.gov/39648698/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0Jw8smh4E-5Zr6zFE65nhqWWQpkIsyzukjvhc1UzSVt&fc=None&ff=20241209102342&v=2.18.0.post9+e462414

📄 "Article from www.cell.com" . ( December 14, 2024 at 04:19PM)
https://www.cell.com/cell/abstract/S0092-8674(24)00897-3

📄 "Epstein-Barr virus hijacks B cell metabolism to establish persistent infection and drive pathogenesis" . EBV ( December 22, 2024 at 02:53AM)
https://pubmed.ncbi.nlm.nih.gov/39709272/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241222005320&v=2.18.0.post9+e462414

📄 "Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients" . EBV ( December 20, 2024 at 05:23AM)
https://pubmed.ncbi.nlm.nih.gov/39700902/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241220032342&v=2.18.0.post9+e462414

📄 "Epstein-Barr virus lytic replication and cancer" . EBV ( December 20, 2024 at 05:23AM)
https://pubmed.ncbi.nlm.nih.gov/39700641/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241220032342&v=2.18.0.post9+e462414

📄 "EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma" . EBV ( December 19, 2024 at 08:23AM)
https://pubmed.ncbi.nlm.nih.gov/39695702/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241219062301&v=2.18.0.post9+e462414

📄 "Association of PD-L1 positivity with Epstein Barr virus infection and microsatellite instability in gastric carcinomas with lymphoid stroma" . EBV ( December 28, 2024 at 04:06PM)
https://pubmed.ncbi.nlm.nih.gov/39730741/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241228140605&v=2.18.0.post9+e462414

📄 "EBV and post-transplant lymphoproliferative disorder: a complex relationship" . EBV ( December 7, 2024 at 07:12PM)
https://pubmed.ncbi.nlm.nih.gov/39644052/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20241207171204&v=2.18.0.post9+e462414

📄 "In silico analysis of human herpes virus-8 genome: a comparison of the K1, VR1, and VR2 regions for genotyping and global geographical distribution" . KSHV K1 ( January 3, 2025 at 08:53AM)
https://pubmed.ncbi.nlm.nih.gov/39747627/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=14CrWYUMC68AdYTXKDd0hh4uLquZLVP4Wi-clNoJ-jtCCuBMuV&fc=None&ff=20250103065301&v=2.18.0.post9+e462414

📄 "The Functional Interaction Between Epstein-Barr Virus and MYC in the Pathogenesis of Burkitt Lymphoma" . Vírus e Câncer ( January 8, 2025 at 10:44AM)
https://pubmed.ncbi.nlm.nih.gov/39766110/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20250108084413&v=2.18.0.post9+e462414

📄 "Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP-1) Regulates Functional Markers in Intermediate and Non-Classical Monocytes" . EBV ( January 8, 2025 at 09:02AM)
https://pubmed.ncbi.nlm.nih.gov/39766068/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20250108070232&v=2.18.0.post9+e462414

📄 "Genetic variations and clinical significance in young-onset nasopharyngeal cancer: Analysis of EBV interaction with cellular receptor variants and viral glycoproteins" . EBV ( January 10, 2025 at 10:44AM)
https://pubmed.ncbi.nlm.nih.gov/39790874/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20250110084417&v=2.18.0.post9+e462414

📄 "Implications of EBV-Encoded and EBV-Related miRNAs in Tumors" . EBV ( January 10, 2025 at 10:44AM)
https://pubmed.ncbi.nlm.nih.gov/39791165/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20250110084417&v=2.18.0.post9+e462414

📄 "The illustrated guide to a Ph.D." . Matt Might ( January 12, 2025 at 02:58PM)
https://matt.might.net/articles/phd-school-in-pictures/?_nospa=true